Merck Nabs Partial Win In Vioxx Securities Fraud Row

By Zachary Zagger · May 13, 2015, 8:02 PM EDT

A New Jersey federal judge ruled Wednesday that a class alleging securities fraud could not prove Merck & Co. Inc. misrepresented Vioxx's heart attack risks at least prior to a study...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

MERCK & CO., INC., SECURITIES, DERIVATIVE & "ERISA" LITIGATION

Case Number

2:05-cv-01151

Court

New Jersey

Nature of Suit

Labor: Other

Date Filed

February 28, 2005

Case Title

MERCK & CO. INC. SECURITIES LITIGATION IN RE: MDL1658

Case Number

2:05-cv-02367

Court

New Jersey

Nature of Suit

Labor: Other

Date Filed

May 05, 2005

Case Title

IN RE: Merck & Co., Inc., Securities, Derivative & "ERISA" Litigation

Case Number

1658

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Date Filed

October 18, 2004

Recent Articles By Zachary